ChineseInvestors.com, Inc. (OTCQB: CIIX), the premier financial information website for Chinese-speaking investors, this morning announced that its wholly owned foreign enterprise, CBD Biotechnology Co. Ltd., has launched a two-tier direct selling initiative to accelerate its CBD sales into China. The company also announced its appointment of marketing expert Fengxian Xie as president of its CBD Community Center in Shanghai, effective immediately. Per the update, the goal of the CBD Community Center initiative is to establish a new, effective marketing channel to further stimulate demand for CBD Biotech’s innovative CBD-infused skin care products. “I am honored to have been chosen to take the lead in building this CBD direct selling community,” Xie stated in the news release. “ChineseInvestors.com has a tremendous competitive advantage in that we are one of the first companies to offer hemp-infused skin care products in China. I look forward to expanding the community’s reach to every city within China.”
To view the full press release, visit http://cnw.fm/7LJ4z
About ChineseInvestors.com
Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail and online sales of hemp-based products and other health related products. For more information, visit the company’s website at www.ChineseInvestors.com
More from CannabisNewsBreaks
About HempWire
HempWire (HW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) HempNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.
For more information please visit https://www.hempwire.com
Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/
HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net
Golden Triangle Ventures (OTC: GTVH) (“GTV”) has completed a major restructuring of its capital structure and…
InMed Pharmaceuticals (NASDAQ: INM), a pharmaceutical company developing small molecule drug candidates for diseases with…
CannabisNewsWire (CNW), a trusted communications platform within the cannabis sector and a part of InvestorBrandNetwork…
Turning Point Brands (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, recently…
WEED Inc. (OTCQB: BUDZ), a global cannabis and hemp bioresearch company based in the U.S.,…
Flora (NASDAQ: FLGC) has closed a registered direct offering to institutional investors for the aggregate…